1. Home
  2. SLDB vs GMRS Comparison

SLDB vs GMRS Comparison

Compare SLDB & GMRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

SELL

Current Price

$6.43

Market Cap

623.0M

Sector

Health Care

ML Signal

SELL

GMRS

GMR Solutions Inc. Class A Common Stock

SELL

Current Price

$10.11

Market Cap

551.0M

ML Signal

SELL

Company Overview

Basic Information
Metric
SLDB
GMRS
Founded
2013
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
623.0M
551.0M
IPO Year
2017
2026

Fundamental Metrics

Financial Performance
Metric
SLDB
GMRS
Price
$6.43
$10.11
Analyst Decision
Strong Buy
Buy
Analyst Count
15
8
Target Price
★ $18.71
$18.38
AVG Volume (30 Days)
★ 1.2M
1.1M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 34.97
N/A
EPS
N/A
★ 0.31
Revenue
★ $8,094,000.00
N/A
Revenue This Year
N/A
$4.72
Revenue Next Year
N/A
$5.81
P/E Ratio
★ N/A
$32.32
Revenue Growth
N/A
★ N/A
52 Week Low
$4.65
$9.00
52 Week High
$11.45
$15.98

Technical Indicators

Market Signals
Indicator
SLDB
GMRS
Relative Strength Index (RSI) 46.83 38.45
Support Level $6.25 $9.62
Resistance Level $6.58 $10.93
Average True Range (ATR) 0.50 0.91
MACD 0.02 -0.14
Stochastic Oscillator 30.12 3.34

Price Performance

Historical Comparison
SLDB
GMRS

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

About GMRS GMR Solutions Inc. Class A Common Stock

GMR Solutions Inc is a holding company, along with its various subsidiaries, that delivers compassionate, quality medical care, meeting a patient's unplanned and planned care needs. The group provides emergent, non-emergent, disaster response, and event medical services across the healthcare ecosystem, serving local communities, health systems, payors, public health, and local, state, and federal agencies within the United States.

Share on Social Networks: